Australia And New Zealand Wound Care Market Growth & Trends:
The Australia and New Zealand wound care market size is anticipated to reach USD 820.17 million by 2030, expanding at a CAGR of 5.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. It encompasses a variety of products, services, and practices aimed at promoting effective healing for various types of wounds.
Healthcare expenditures continue to rise in Australia and New Zealand (ANZ), and introducing innovative wound care solutions leads to increased investment in advanced wound management technologies. This ultimately benefits patients who require effective treatment for chronic and complex wounds. For instance, in September 2023, MiMedx Group, Inc. introduced EPIEFFECT as the latest addition to its range of advanced wound care products.
The growing elderly population in ANZ countries drives increased demand for advanced wound care products and services tailored to the unique needs of aging patients. Healthcare providers and policymakers must prioritize investing in innovative wound management solutions to address the challenges this aging demographic trend poses effectively.
Australia And New Zealand Wound Care Market Report Highlights:
- Based on product, the advanced wound dressing category commands the largest share of revenue within the product segment of the market. This dominance is primarily attributed to several critical factors. There is a rising incidence of chronic wounds, including diabetic ulcers and pressure sores
- Based on application, the chronic wound segment dominated the market, accounting for 60.0% of revenue share owing to the advancements in wound care technologies, including bioengineered tissues, negative pressure wound therapy (NPWT), and antimicrobial dressings, which have revolutionized the treatment landscape for chronic wounds. These innovations enhance healing rates and improve patient outcomes and quality of life
- Based on end use, the hospital segment is dominant due to the rising geriatric population in ANZ is leading to an increase in age-related health issues that often require extensive wound care management
- Based on the mode of purchase, in 2023, the prescribed segment led the market, with a 62.7% share. This dominance is driven by an increasing reliance on healthcare professionals for wound management, as prescribed products are often tailored to meet the specific needs of patients with various wound types
- Based on distribution channel, institutional sales held the largest revenue share in the market. By targeting institutional buyers, wound care companies can streamline their distribution channels, ensure proper storage and handling of their products, and provide targeted training and support to healthcare professionals